Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 23482847)

1.

Trial watch: Monoclonal antibodies in cancer therapy.

Vacchelli E, Eggermont A, Galon J, Sautès-Fridman C, Zitvogel L, Kroemer G, Galluzzi L.

Oncoimmunology. 2013 Jan 1;2(1):e22789.

2.

Trial Watch: Adoptive cell transfer for anticancer immunotherapy.

Aranda F, Vacchelli E, Obrist F, Eggermont A, Galon J, Hervé Fridman W, Cremer I, Tartour E, Zitvogel L, Kroemer G, Galluzzi L.

Oncoimmunology. 2014 May 1;3:e28344. eCollection 2014. Review.

3.

Trial Watch: DNA vaccines for cancer therapy.

Pol J, Bloy N, Obrist F, Eggermont A, Galon J, Hervé Fridman W, Cremer I, Zitvogel L, Kroemer G, Galluzzi L.

Oncoimmunology. 2014 Jan 1;3(1):e28185. Epub 2014 Apr 1. Review.

4.

Trial Watch: Chemotherapy with immunogenic cell death inducers.

Vacchelli E, Aranda F, Eggermont A, Galon J, Sautès-Fridman C, Cremer I, Zitvogel L, Kroemer G, Galluzzi L.

Oncoimmunology. 2014 Jan 1;3(1):e27878. Epub 2014 Mar 1. Review.

5.

Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy.

Aranda F, Vacchelli E, Eggermont A, Galon J, Fridman WH, Zitvogel L, Kroemer G, Galluzzi L.

Oncoimmunology. 2014 Jan 1;3(1):e27297. Epub 2014 Feb 1.

6.

Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapy.

Vacchelli E, Aranda F, Eggermont A, Galon J, Sautès-Fridman C, Zitvogel L, Kroemer G, Galluzzi L.

Oncoimmunology. 2014 Jan 1;3(1):e27048. Review.

7.

Trial Watch: Peptide vaccines in cancer therapy.

Aranda F, Vacchelli E, Eggermont A, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G, Galluzzi L.

Oncoimmunology. 2013 Dec 1;2(12):e26621. Epub 2013 Nov 4. Review.

8.

Trial watch: Dendritic cell-based interventions for cancer therapy.

Vacchelli E, Vitale I, Eggermont A, Fridman WH, Fučíková J, Cremer I, Galon J, Tartour E, Zitvogel L, Kroemer G, Galluzzi L.

Oncoimmunology. 2013 Oct 1;2(10):e25771. Epub 2013 Jul 29. Review.

9.

Trial Watch: Toll-like receptor agonists for cancer therapy.

Vacchelli E, Eggermont A, Sautès-Fridman C, Galon J, Zitvogel L, Kroemer G, Galluzzi L.

Oncoimmunology. 2013 Aug 1;2(8):e25238. Epub 2013 Jun 10. Review.

10.

Trial Watch: Immunostimulatory cytokines.

Vacchelli E, Eggermont A, Fridman WH, Galon J, Zitvogel L, Kroemer G, Galluzzi L.

Oncoimmunology. 2013 Jul 1;2(7):e24850. Epub 2013 May 7. Review.

11.

Trial Watch: Adoptive cell transfer for anticancer immunotherapy.

Vacchelli E, Eggermont A, Fridman WH, Galon J, Tartour E, Zitvogel L, Kroemer G, Galluzzi L.

Oncoimmunology. 2013 May 1;2(5):e24238.

12.

Trial watch: Chemotherapy with immunogenic cell death inducers.

Vacchelli E, Senovilla L, Eggermont A, Fridman WH, Galon J, Zitvogel L, Kroemer G, Galluzzi L.

Oncoimmunology. 2013 Mar 1;2(3):e23510.

13.

Targeted immunotherapy for high-risk neuroblastoma--the role of monoclonal antibodies.

Parsons K, Bernhardt B, Strickland B.

Ann Pharmacother. 2013 Feb;47(2):210-8. doi: 10.1345/aph.1R353. Epub 2013 Feb 5. Review.

PMID:
23386066
14.

[An overview of antibody therapy against cancer].

Taniguchi H, Imai K.

Nihon Rinsho. 2012 Dec;70(12):2087-92. Review. Japanese.

PMID:
23259378
15.

Trial watch: Dendritic cell-based interventions for cancer therapy.

Galluzzi L, Senovilla L, Vacchelli E, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G.

Oncoimmunology. 2012 Oct 1;1(7):1111-1134.

16.

Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia.

Bauer K, Rancea M, Roloff V, Elter T, Hallek M, Engert A, Skoetz N.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD008079. doi: 10.1002/14651858.CD008079.pub2. Review.

PMID:
23152253
17.

Targetting esophageal and gastric cancers with monoclonal antibodies.

Norguet E, Dahan L, Seitz JF.

Curr Top Med Chem. 2012;12(15):1678-82. Review.

PMID:
22978338
18.

Anti-tumor monoclonal antibodies in conjunction with β-glucans: a novel anti-cancer immunotherapy.

Xiang D, Sharma VR, Freter CE, Yan J.

Curr Med Chem. 2012;19(25):4298-305. Review.

PMID:
22834812
19.

Trial Watch: Adoptive cell transfer immunotherapy.

Galluzzi L, Vacchelli E, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G.

Oncoimmunology. 2012 May 1;1(3):306-315.

20.

Trial Watch: Monoclonal antibodies in cancer therapy.

Galluzzi L, Vacchelli E, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zucman-Rossi J, Zitvogel L, Kroemer G.

Oncoimmunology. 2012 Jan 1;1(1):28-37.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk